Avisa Myko Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 4

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $200K

  • Investors
  • 4

Avisa Myko General Information

Description

Developer of a precision fermentation technology designed to produce melanin at scale and affordable cost. The company currently designs a prototype of sunscreen using melanin as an ultraviolet blocker and without using any existing chemical or mineral ultraviolet blockers in the formulation, enabling clients to avail affordable natural melanin at low costs.

Contact Information

Website
www.avisamyko.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • IndieBio 479, Jessie Street, 3rd Street
  • Suite 318, 2565
  • San Francisco, CA 94103
  • United States
+1 (415)
Primary Industry
Biotechnology
Other Industries
Other Energy Services
Vertical(s)
Industrials, Life Sciences
Corporate Office
  • IndieBio 479, Jessie Street, 3rd Street
  • Suite 318, 2565
  • San Francisco, CA 94103
  • United States
+1 (415)

Avisa Myko Timeline

2021202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Avisa Myko Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Seed Round 23-Feb-2024 $200K Completed Generating Revenue
6. Debt - General 30-Nov-2023 Completed Generating Revenue
5. Seed Round 09-Aug-2023 Completed Generating Revenue
4. Seed Round 18-Feb-2022 Completed Generating Revenue
3. Early Stage VC 29-Jan-2021 Completed Generating Revenue
2. Early Stage VC 15-Jan-2020 $50K $300K Completed Generating Revenue
1. Accelerator/Incubator 25-Sep-2019 $250K $250K Completed Generating Revenue
To view Avisa Myko’s complete valuation and funding history, request access »

Avisa Myko Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a precision fermentation technology designed to produce melanin at scale and affordable cost. The company c
Biotechnology
San Francisco, CA
4 As of 2024

Baltimore, MD
 

Cambridge, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Avisa Myko Competitors (9)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
MelaTech Accelerator/Incubator Backed Baltimore, MD
Seaspire Skincare Venture Capital-Backed Cambridge, MA
Gadusol Laboratories Formerly VC-backed Corvallis, OR
Insectta Venture Capital-Backed Singapore, Singapore
Sóliome Venture Capital-Backed San Francisco, CA
You’re viewing 5 of 9 competitors. Get the full list »

Avisa Myko Patents

  • 2

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 2

    Pending

  • Expiring in next 12 mo

Avisa Myko Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20230106900-A1 Protection from ionizing radiation Pending 26-Mar-2020
CA-3164397-A1 Protection from ionizing radiation Pending 06-Feb-2020

Avisa Myko Executive Team (2)

Name Title Board Seat
Ravi Adgulwar Co-Founder, Chief Executive Officer & Board Member
Sheshagiri Raghukumar Ph.D Co-Founder, Chief Scientific Officer & Board Member
To view Avisa Myko’s complete executive team members history, request access »

Avisa Myko Board Members (4)

Name Representing Role Since
Mark Goldstein Advisors.Fund Chairman
Ravi Adgulwar Avisa Myko Co-Founder, Chief Executive Officer & Board Member
Sheshagiri Raghukumar Ph.D Avisa Myko Co-Founder, Chief Scientific Officer & Board Member
You’re viewing 3 of 4 board members. Get the full list »

Avisa Myko Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Avisa Myko Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
VII Ventures Venture Capital Minority
Advisors.Fund Venture Capital Minority
IndieBio Accelerator/Incubator Minority
SOSV Venture Capital Minority
To view Avisa Myko’s complete investors history, request access »

Ready to get started?

Request a free trial

Avisa Myko FAQs

  • When was Avisa Myko founded?

    Avisa Myko was founded in 2019.

  • Who is the founder of Avisa Myko?

    Ravi Adgulwar and Sheshagiri Raghukumar Ph.D are the founders of Avisa Myko.

  • Who is the CEO of Avisa Myko?

    Ravi Adgulwar is the CEO of Avisa Myko.

  • Where is Avisa Myko headquartered?

    Avisa Myko is headquartered in San Francisco, CA.

  • What is the size of Avisa Myko?

    Avisa Myko has 4 total employees.

  • What industry is Avisa Myko in?

    Avisa Myko’s primary industry is Biotechnology.

  • Is Avisa Myko a private or public company?

    Avisa Myko is a Private company.

  • What is Avisa Myko’s current revenue?

    The current revenue for Avisa Myko is .

  • How much funding has Avisa Myko raised over time?

    Avisa Myko has raised $1.45M.

  • Who are Avisa Myko’s investors?

    VII Ventures, Advisors.Fund, IndieBio, and SOSV have invested in Avisa Myko.

  • Who are Avisa Myko’s competitors?

    MelaTech, Seaspire Skincare, Gadusol Laboratories, Insectta, and Sóliome are some of the 9 competitors of Avisa Myko.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »